Multiple sclerosis and COVID‐19: How many are at risk?

BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their risk for and by severe acute respiratory syndrome coronavirus 2 and in guiding disease‐modifying treatment (DMT). The objective was to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Neurol
Huvudupphovsmän: Bsteh, Gabriel, Bitschnau, Christina, Hegen, Harald, Auer, Michael, Di Pauli, Franziska, Rommer, Paulus, Deisenhammer, Florian, Berger, Thomas
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2020
Ämnen:
Multiple Sclerosis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537184/
https://ncbi.nlm.nih.gov/pubmed/32978860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.14555
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk